Migraine treatment shows promise for glaucoma prevention
Treatment with CGRP inhibitors, a class of drugs used to prevent migraine, appears to be associated with a reduced risk of glaucoma, researchers reported on May 6, 2026… read more.
Treatment with CGRP inhibitors, a class of drugs used to prevent migraine, appears to be associated with a reduced risk of glaucoma, researchers reported on May 6, 2026… read more.
NICE(UK): Vorasidenib can be used as an option to treat grade 2 astrocytoma or oligodendroglioma in people 12 years and over when: i) the cancer has a susceptible… read more.
People with insurance through an employer or another commercial plan experienced an average wait time of 50 days for their first visit with a neurology provider, according to… read more.
H. Lundbeck A/S y presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 Annual Meeting, underscoring the importance of evaluating… read more.
Roche announced that its Elecsys Neurofilament Light Chain (NfL) test has received CE mark approval for the detection of neuroinflammation in patients diagnosed with relapsing remitting multiple sclerosis… read more.
Air pollution is associated with increased migraine activity, according to a study published on April 15, 2026, in Neurology®, the medical journal of the American Academy of Neurology. Both short-term… read more.
A new study published in Otolaryngology–Head and Neck Surgery, the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), finds that two common and treatable causes… read more.
Lundbeck announced that new data across its neurology portfolio will be presented at the American Academy of Neurology (AAN) Annual Meeting 2026, taking place April 18–22 in Chicago,… read more.
A new blood test, using a marker for late-stage Alzheimer’s disease, could offer a clinically relevant dementia diagnosis with fewer false positives, according to researchers at Lund University… read more.
In 2023, globally 259,000 people died from meningitis and 2.5 million people were infected with the disease, suggests a study published in The Lancet Neurology. Although death and infection rates have declined significantly… read more.
Older adults who develop delirium during a hospital admission face a substantially higher risk of dementia in later years, even if they had no prior health conditions, according… read more.
A new study reveals that family caregivers of Alzheimer’s patients in Oman face significant unmet needs, ranging from limited knowledge about the disease to high psychological stress and… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.